Skip to main content

Cingulate Inc.

CING
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001862150

No open-market purchases or sales by Cingulate Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $9.88M in total; no superinvestor holds it.

Other share classesCINGW

Superinvestors holding CING, Q2 2026

See all superinvestors

No superinvestor reported holding CING in Q2 2026.